|
Volumn 45, Issue , 2002, Pages 104-107
|
Efficacy and tolerability of acemetacin, a non-steroidal anti-inflammatory drug, in Mexican patients: Result of the ETAPAM study
a a a a
a
Bayer Company
(Mexico)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACEMETACIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
DRUG DERIVATIVE;
INDOMETACIN;
ADULT;
ANALGESIA;
ARTHRITIS;
CARDIOVASCULAR DISEASE;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPEPSIA;
ETHNIC GROUP;
FEMALE;
GASTRITIS;
GASTROINTESTINAL SYMPTOM;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEXICO;
MUSCULOSKELETAL DISEASE;
NAUSEA;
NEUROLOGIC DISEASE;
PAIN;
PAIN ASSESSMENT;
RESPIRATORY TRACT DISEASE;
SENSORY DYSFUNCTION;
SKIN DISEASE;
UROGENITAL TRACT DISEASE;
AGED;
ARTICLE;
CLINICAL TRIAL;
MIDDLE AGED;
PROSPECTIVE STUDY;
RHEUMATIC DISEASE;
SPORT INJURY;
ADULT;
AGED;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ATHLETIC INJURIES;
FEMALE;
HUMANS;
INDOMETHACIN;
MALE;
MEXICO;
MIDDLE AGED;
PAIN;
PAIN MEASUREMENT;
PROSPECTIVE STUDIES;
RHEUMATIC DISEASES;
|
EID: 0036034036
PISSN: 00838969
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (13)
|
References (20)
|